Novo Nordisk shares down 2% as co lowers price of Wegovy and Ozempic for existing self pay patients in US

lunes, 17 de noviembre de 2025, 7:55 am ET1 min de lectura
NVO--

Novo Nordisk shares down 2% as co lowers price of Wegovy and Ozempic for existing self pay patients in US

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios